Medtronic plc (mdt)
MDT Valuation
| P/E (trailing) | 23.03 |
| P/E (forward) | 13.40 |
| EV/EBITDA | 12.92 |
| Price/Sales | 3.02 |
| Price/Book | 2.22 |
| Market cap | $109.98B |
Medtronic plc FAQ
What does Medtronic plc (MDT) do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio…
What is MDT's P/E ratio?
Medtronic plc has a trailing P/E of 23.03× based on publicly available market data.
Does MDT pay a dividend?
Indicated dividend yield: 3.4%. Confirm ex-dates and payout history in Vest Terminal.
What sector is MDT in?
Medtronic plc is classified in Healthcare (Medical Devices) on NYQ.
What is MDT's market capitalization?
Approximate market cap: $109.98B.
What are the main risks for MDT?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of MDT?
Potential positives include revenue growth of 9.9% year-over-year, earnings growth of 18.3% year-over-year.
Where can I get analyst estimates for MDT?
Consensus estimates, price targets, and detailed analyst data for Medtronic plc are available to Professional subscribers in Vest Terminal — not on this public summary page.